Protocols.io

Berkeley, United States Founded: 2012 • Age: 14 yrs
Life science protocol repository

About Protocols.io

Protocols.io is a company based in Berkeley (United States) founded in 2012. Protocols.io has raised $500 thousand across 3 funding rounds from investors including Lighthouse Capital Management. Protocols.io offers products and services including Protocols.io Platform and Protocols.io Editor. Protocols.io operates in a competitive market with competitors including Causaly, ScienceIO, Collaborative Drug Discovery, Qrativ and Kudos, among others.

  • Headquarter Berkeley, United States
  • Sectors
    Healthcare
  • Website category Science and Education · Biology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website protocols.io
  • Social LinkedIn X Facebook
Key Metrics

Products & Services of Protocols.io

Protocols.io offers a comprehensive portfolio of products and services, including Protocols.io Platform and Protocols.io Editor.

Protocols.io Platform
Research Collaboration Tool

Secure system for developing and sharing research methods online.

Protocols.io Editor
Method Development Tool

Tool for creating and editing reproducible research protocols.

Funding Insights of Protocols.io

Protocols.io has successfully raised a total of $500K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $25 thousand completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $500,000
  • Total Rounds 3
  • Last Round Seed β€” $25,000
  • First Round $250,000

    (Aug 2012)

  • Investors Count 1

All 3 funding rounds of Protocols.io with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2016$25,000Seed––
–
Aug 2014$225,000Seed–Lighthouse Capital Management
–
Aug 2012$250,000Seed––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Protocols.io

Protocols.io has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Lighthouse Capital Management.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital investments are directed toward US and Chinese markets.
–lighthousecapital.cnHuangpu, China
Premium access

Investor details for Protocols.io

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Protocols.io

5 people are tracked at Protocols.io (2 in leadership, 3 in team).

NameRoleGroup
Lenny Teytelman
Founder And PresidentLeadership
Emma Ganley
Director of Strategic InitiativesLeadership
Forrest Jordan
AdvisorTeam
Bogdan Bogdanov
Junior Full-Stack Web DeveloperTeam
Joe Duncan
AdvisorTeam
Premium access

Complete people profiles for Protocols.io

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Protocols.io

3 dated milestones of Protocols.io across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Protocols.io is founded.
  2. Funding First funding round of $250K.
  3. Funding Latest funding round, Seed, of $25K.

Competitors of Protocols.io

Protocols.io operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Causaly, ScienceIO, Collaborative Drug Discovery, Qrativ and Kudos, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
causaly.com2017London, United Kingdom$90.72M62
AI-based data-mining tools for scientific evidence discovery are provided.
science.io2020Boston, United States$8M22
Provider of AI solutions transforming medical text into enriched healthcare data
collaborativedrug.com2004Burlingame, United States–31
Biological and chemical data are managed securely in a database.
qrativ.bio2017Cambridge, United States$8.3M–
AI based drug purposing platform to identify treatments for rare diseases
growkudos.com2013Oxford, United Kingdom$2.5M12
Research communication services are provided to boost visibility and impact.
docphin.com2010New York, United States$1M–
Medical news and research are personalized for physicians.
citelighter.com2011New York, United States$6.58M–
Digital writing solution for K-20 students
longenesis.com2017Riga, Latvia$1.19M16
Digital platform for healthcare research and patient engagement
biosymetrics.com2015New York, United States$4.88M–
Provider of a cognitive computing-based biomedical intelligence platform
Premium access

Detailed competitors of Protocols.io

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Protocols.io

The website of Protocols.io (protocols.io) receives about 357.9K visits a month and ranks #143,445 among all websites worldwide, #9,245 in Biology.

  • Monthly visits
    357.9K

    ▲ 9.6% vs previous month

  • Unique visitors
    147.1K

    per month

  • Global rank
    #143,445

    among all websites

  • Category rank
    #9,245

    Science and Education · Biology

Similar websites

Websites whose visitors overlap most with Protocols.io. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
addgene.org
addgene.org
100%
–#84,256–
biorxiv.org
99%
3M#19,954View details
benchling.com
99%
1.4M#36,159View details
cell.com
98%
5M#14,619View details
scisure.com
scisure.com
97%
–#907,030–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Protocols.io

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Protocols.Io

Premium access

Complete news archive for Protocols.io

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Protocols.io

10 companies that operate in the same segment as Protocols.io (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Protocols.io

Protocols.io was founded in 2012.

Protocols.io is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.

Protocols.io is a funded company, having raised a total of $500K across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Aug 2012.

Protocols.io was founded in 2012 in Berkeley, United States, as a repository for life science clinical trial protocols. The platform is operated within the biotechnology sector, utilizing web and mobile technologies for knowledge discovery and sharing. Protocols are cloned, modified, and discussed by users, while personal protocols are created and collaborative groupsprivate or publicare formed. Reference libraries are uploaded, and recommendations for recent articles are generated based on user activity.

Protocols.io's top competitors include Causaly, ScienceIO and BioSymetrics.

Protocols.io offers Protocols.io Platform and Protocols.io Editor.

Protocols.io has 1 investor. Key investors include Lighthouse Capital Management.

The website of Protocols.io receives about 358 thousand visits a month and ranks #143,445 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available